Blood test may replace biopsies for kidney transplant patients
NCT ID NCT07231328
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 600 kidney transplant patients to see if a blood test (TruGraf and TRAC) can help doctors manage immunosuppression and detect early signs of rejection. The goal is to improve long-term outcomes by reducing the need for invasive biopsies. Participants will be monitored for 24 months after their transplant.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIOMARKERS / BLOOD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A gentle hand: could better nursing support calm the fear of prostate biopsy?
- Can your gut bacteria change how transplant drugs work?
- Your gut bacteria might predict transplant rejection
- Centenarians put to the test: can exercise reverse frailty at age 100?
- Centenarians in spain offer clues to living past 100 in good health
- Hidden toll of routine ICU procedure revealed: suctioning may spike pain and stress